During this visit to TOS 2025, Prof. Hafezi presented ECO-CAIRS and ELZA-PACE and highlighted the Light for Sight Foundation’s work to improve care for children with Down Syndrome.
Prof. Farhad Hafezi, MD, PhD, FARVO, has been appointed to the Editorial Board of EuroTimes, the official publication of the European Society of Cataract and Refractive Surgeons (ESCRS). This role further solidifies his contributions to ophthalmic research, education, and innovation.
Nikki Hafezi-Kristoffersen, MAS IP ETHZ, CEO of the ELZA Institute and executive at the MESCA Foundation, recently visited the Bukhara State Medical Institute (BSMI).
Our latest review on corneal cross-linking (CXL), published in Progress in Retinal and Eye Research, explores its evolution, advanced protocols like ELZA-PACE, and clinical applications.
Visit ELZA Zurich HB, our modern eye clinic in Zurich Hauptbahnhof. Find us at Bahnhofplatz 15, 2nd floor, Ostrisalit – above The Counter.
A significant part of the symposium was dedicated to showcasing collaborative initiatives between Switzerland and Uzbekistan, particularly in healthcare. One example was a keratoconus screening initiative led by Ms. Nikki Hafezi, ELZA’s CEO, and a graduate of ETH Zürich and the University of Bern. This project, undertaken with local NGOs, provided vision screenings to 117 families, identifying three children with keratoconus. These children received further medical consultations and guidance for managing the condition.
Prof. Farhad Hafezi from the ELZA Institute provided an insightful update on the Second Global Consensus on Keratoconus during an interview with EyeTube.
In a recently published case report in American Journal of Ophthalmology Case Reports, our team, in collaboration with Brazilian colleagues, describes an unusual case of a “CTK-like syndrome” following sequential intracorneal ring segment (ICRS) implantation and corneal cross-linking (CXL) in a young patient with progressive keratoconus.
Innovations in Corneal Cross-Linking (CXL): A Look at 25 Years of Progress
Nikki Hafezi, a partner of MESCA Foundation, is leading healthcare transformation in Uzbekistan. MESCA, founded in 2021 by Bakhtiyor Fazylov, focuses on medical education, training, and research. It aims to enhance ophthalmological care, particularly addressing keratoconus, a significant cause of preventable blindness in children. MESCA’s initiatives include training local healthcare professionals and collaborating with institutions like the Andijan State Medical Institute to improve medical practice and education.
